Charles River Laboratories International, Inc. News Headlines

CRL 
$64.29
*  
0.70
1.1%
Get CRL Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Actavis' Alzheimer's Drug Approved; Bystolic Gets CRL - Analyst Blog
12/26/2014 1:20:00 PM - Zacks.com


Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog
12/23/2014 4:50:00 PM - Zacks.com


Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog
12/23/2014 4:50:00 AM - Investopedia


Healthways-TAL to Improve Well-Being Solutions in Australia - Analyst Blog
12/18/2014 6:25:00 PM - Zacks.com


Healthways-TAL to Improve Well-Being Solutions in Australia - Analyst Blog
12/18/2014 6:25:00 AM - Investopedia


ICON (ICLR) Now a Strong Buy: Should It Be in Your Portfolio? - Analyst Blog
12/16/2014 6:00:00 PM - Zacks.com


ICON (ICLR) Now a Strong Buy: Should It Be in Your Portfolio? - Analyst Blog
12/16/2014 6:00:00 AM - Investopedia


Cancer Genetics (CGIX) Looks Good: Stock Rises 8% - Tale of the Tape
12/11/2014 9:25:00 AM - Zacks.com


BioTelemetry (BEAT) Catches Eye: Stock Jumps 5.7% - Tale of the Tape
11/28/2014 8:30:00 AM - Zacks.com


Bristol-Myers Squibb's HCV Drug Daclatasvir Receives CRL - Analyst Blog
11/27/2014 1:00:00 PM - Zacks.com


Avanir's Migraine Drug Gets Complete Response Letter - Analyst Blog
11/27/2014 11:50:00 AM - Zacks.com


Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
11/14/2014 3:39:00 PM - Zacks.com


Intrexon (XON) Looks Good: Stock Moves 11% Higher - Tale of the Tape
11/12/2014 9:46:00 AM - Zacks.com


Dynavax's Heplisav Phase III Trial Recommended to Continue - Analyst Blog
11/11/2014 5:30:00 PM - Zacks.com


Strength Seen in Covance (CVD): Stock Surges 25.9% - Tale of the Tape
11/4/2014 9:25:00 AM - Zacks.com


Charles River Laboratories (CRL) Has Risen To A New High For The Year
11/3/2014 9:49:00 AM - RTT News


Acorda (ACOR) Beats on Q3 Earnings, Ups Ampyra Outlook - Analyst Blog
10/31/2014 12:20:00 PM - Zacks.com


Cramer's Mad Money - Charles River Labs Battles Ebola (10/30/14)
10/31/2014 5:46:00 AM - Seeking Alpha


Charles River (CRL) Beats on Q3 Earnings, Guidance Upped - Analyst Blog
10/30/2014 11:30:00 AM - Zacks.com


Charles River Laboratories Q3 14 Earnings Conference Call At 9:00 AM ET
10/30/2014 8:00:00 AM - RTT News


Charles River Laboratories Q3 Profit Rises, Lifts Outlook
10/29/2014 7:57:00 PM - RTT News


Earnings Reaction History: Charles River Laboratories, 100.0% Follow-Through Indicator, 2.5% Sensitive
10/29/2014 2:03:54 PM - MT Newswires


Express Scripts Reports In-Line Q3 Earnings, Narrows View - Analyst Blog
10/29/2014 1:26:00 PM - Zacks.com


McKesson Beats on Q2 Earnings, Revenues; Keeps Guidance - Analyst Blog
10/29/2014 10:14:00 AM - Zacks.com


Will Cigna's (CI) Business Diversity Drive Q3 Earnings Beat? - Analyst Blog
10/28/2014 5:01:00 PM - Zacks.com